These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5345 related items for PubMed ID: 9164515

  • 21. Confocal endomicroscopy in patients with ulcerative colitis.
    Watanabe O, Ando T, Maeda O, Hasegawa M, Ishikawa D, Ishiguro K, Ohmiya N, Niwa Y, Goto H.
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S286-90. PubMed ID: 19120913
    [Abstract] [Full Text] [Related]

  • 22. [Colo-rectal precancerous conditions: anatomo-pathologic and clinical aspects].
    Melita P, Calbo L, Lemma F, Barbuscia M, Belnome NA, Palmeri R, Lorenzini C.
    Chir Ital; 1984 Apr; 36(2):215-26. PubMed ID: 6525685
    [Abstract] [Full Text] [Related]

  • 23. Variation in the argyrophil cell population of the rectum in ulcerative colitis and adenocarcinoma.
    Gledhill A, Enticott ME, Howe S.
    J Pathol; 1986 Aug; 149(4):287-91. PubMed ID: 2428963
    [Abstract] [Full Text] [Related]

  • 24. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
    Freitas D, Goulão MH, Camacho E, Figueiredo P, Ministro P, Ferreira M, Portela F, Andrade P, Donato A, Martins MI.
    Hepatogastroenterology; 2002 Aug; 49(47):1269-74. PubMed ID: 12239922
    [Abstract] [Full Text] [Related]

  • 25. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.
    Cartwright CA, Coad CA, Egbert BM.
    J Clin Invest; 1994 Feb; 93(2):509-15. PubMed ID: 7509341
    [Abstract] [Full Text] [Related]

  • 26. Flow cytometry and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer.
    Paganelli GM, Lalli E, Facchini A, Biasco G, Santucci R, Brandi G, Barbara L.
    Am J Gastroenterol; 1994 Feb; 89(2):220-4. PubMed ID: 8304307
    [Abstract] [Full Text] [Related]

  • 27. Malignant potential of chronic ulcerative colitis. Preliminary report.
    Nugent FW, Haggit RC, Colcher H, Kutteruf GC.
    Gastroenterology; 1979 Jan; 76(1):1-5. PubMed ID: 758130
    [Abstract] [Full Text] [Related]

  • 28. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D, Mantellini P, Calabrò A, Panerai C, Amorosi A, Paladini I, Salvadori G, Garcea MR, Surrenti C.
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [Abstract] [Full Text] [Related]

  • 29. [Precancerous lesions of the colon and rectum].
    Igarashi T, Akimoto S, Otasiro Y, Hanyu F, Nagasako K.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1639-44. PubMed ID: 2730060
    [Abstract] [Full Text] [Related]

  • 30. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB.
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [Abstract] [Full Text] [Related]

  • 31. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
    Risio M, Candelaresi G, Rossini FP.
    Cancer Epidemiol Biomarkers Prev; 1993 Jun; 2(4):363-7. PubMed ID: 8102291
    [Abstract] [Full Text] [Related]

  • 32. Possibility of different cancer development between the proximal and distal colon: comparison of the distribution between adenomatous polyps and cancer.
    Ikeda Y, Mori M, Koyanagi N, Minagawa S, Kondo N, Fujimaru R, Kojima Y, Kondo A, Sugimachi K.
    Hepatogastroenterology; 1998 Jun; 45(23):1583-6. PubMed ID: 9840109
    [Abstract] [Full Text] [Related]

  • 33. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J, McKinley M, Kahn E, Stiel L, Rosa J, Grancher K, Daum F.
    Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
    [Abstract] [Full Text] [Related]

  • 34. Distribution of dysplasia in ulcerative colitis.
    Vatn MH, Elgjo K, Bergan A.
    Scand J Gastroenterol; 1984 Oct; 19(7):893-5. PubMed ID: 6531658
    [Abstract] [Full Text] [Related]

  • 35. Deficiency of colonic telomerase in ulcerative colitis.
    Usselmann B, Newbold M, Morris AG, Nwokolo CU.
    Am J Gastroenterol; 2001 Apr; 96(4):1106-12. PubMed ID: 11316155
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Labeling index in colonic cancer, polyps and polyposis and nonspecific colitis].
    Blokhina NG, Romanova LF, Kirkin BB, Markova EV, Chizhikov BA.
    Vopr Onkol; 1986 Apr; 32(8):53-6. PubMed ID: 3765509
    [Abstract] [Full Text] [Related]

  • 38. Serum and colon mucosa micronutrient antioxidants: differences between adenomatous polyp patients and controls.
    Nair S, Norkus EP, Hertan H, Pitchumoni CS.
    Am J Gastroenterol; 2001 Dec; 96(12):3400-5. PubMed ID: 11774956
    [Abstract] [Full Text] [Related]

  • 39. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development.
    Mitsuhashi J, Mikami T, Saigenji K, Okayasu I.
    Pathol Int; 2005 Mar; 55(3):113-21. PubMed ID: 15743319
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 268.